GSK plc GSK announced that the European Medicines Agency has accepted its marketing authorization application (MAA) seeking ...

The global Alagille syndrome market is experiencing significant growth driven by rising awareness, advancements in diagnostic tools, and increased adoption of genetic testing. The market's expansion ...

The EMA has started a review of GSK's treatment candidate for primary biliary cholangitis (PBC), linerixibat, offering hope ...

In a rare, transcendent concert, the 83-year-old maestro and Verdi specialist put his musical wisdom, lifetime experience and ...

Fashion is fun, trendy, and always changing. But the rise of fast fashion comes at a heavy cost to our climate and the planet ...

Biotech stock Mirum Pharmaceuticals has rocketed 236% since its IPO in 2019. Shares are near a buy point after earnings.

Liver cleanse products are growing in popularity, despite little evidence showing benefit.“The idea of a liver cleanse is ...

(Nasdaq: MIRM) today announced that on June 10, 2025, the Compensation Committee of Mirum’s Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 115,620 ...

It has been about a month since the last earnings report for Mirum Pharmaceuticals, Inc. (MIRM). Shares have lost about 1.3% in that time frame, underperforming the S&P 500. Will the recent negative ...

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Liquidia Technologies (LQDA – Research Report), Haemonetics (HAE – Research Re ...

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM), a biopharmaceutical company specializing in therapies for rare liver diseases, has been making significant strides in the market with its growing product ...